1. KONOS. Korean law and regulation related with organ donation and transplantation. Ministry of Health and Welfare [serial on the Internet]. 2013 [cited 2014 Nov 5]. Available from:
http://www.konos.go.kr.
2. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567-80.
3. Kim MS. Modification of emergency status in deceased donor liver allocation: evidence for Korean Model of End-stage Liver Disease (MELD) system. J Korean Soc Transplant 2016; 30: 51-8.
4. Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, et al. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl 2011; 17: 674-84.
5. Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol 2011; 54: 1297-306.
6. Bang SR, Ahn HJ, Kim GS, Yang M, Gwak MS, Ko JS, et al. Predictors of high intraoperative blood loss derived by simple and objective method in adult living donor liver transplantation. Transplant Proc 2010; 42: 4148-50.
7. Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 2010; 11: 234-8.
8. Angeli P, Bezinover D, Biancofiore G, Bienholz A, Findlay J, Paugam Burtz C, et al. Acute kidney injury in liver transplant candidates: a position paper on behalf of the Liver Intensive Care Group of Europe. Minerva Anestesiol 2017; 83: 88-101.
9. Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279-90.
10. Kwon S. Hepatorenal syndrome. Clin Mol Hepatol 2004; 10(3 Suppl): S57-66.
13. Massicotte L, Beaulieu D, Roy JD, Marleau D, Vandenbroucke F, Dagenais M, et al. MELD score and blood product requirements during liver transplantation: no link. Transplantation 2009; 87: 1689-94.
14. Massicotte L, Carrier FM, Karakiewicz P, Hevesi Z, Thibeault L, Nozza A, et al. Impact of MELD score-based organ allocation on mortality, bleeding, and transfusion in liver transplantation: a before-and-after observational cohort study. J Cardiothorac Vasc Anesth 2019; 33: 2719-25.
15. Varotti G, Santori G, Andorno E, Morelli N, Ertreo M, Strada P, et al. Impact of Model for End-Stage Liver Disease score on transfusion rates in liver transplantation. Transplant Proc 2013; 45: 2684-8.
16. Frasco PE, Poterack KA, Hentz JG, Mulligan DC. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg 2005; 101: 30-7.
17. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116: 878-85.
19. Henry Z, Northup PG. The rebalanced hemostasis system in end-stage liver disease and its impact on liver transplantation. Int Anesthesiol Clin 2017; 55: 107-20.
21. Roullet S, Freyburger G, Cruc M, Quinart A, Stecken L, Audy M, et al. Management of bleeding and transfusion during liver transplantation before and after the introduction of a rotational thromboelastometry-based algorithm. Liver Transpl 2015; 21: 169-79.
23. Xia VW, Du B, Braunfeld M, Neelakanta G, Hu KQ, Nourmand H, et al. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl 2006; 12: 614-20.
24. Lee JA, Choi G, Kim JM, David Kwon CH, Joh JW. Comparison study of outcomes of deceased donor liver transplantation before and after Korean Model for End-Stage Liver Disease (MELD) system: single center experience. J Korean Soc Transplant 2018; 32: 7-11.
25. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 2006; 6: 2651-9.
26. Yadav SK, Saraf N, Saigal S, Choudhary NS, Goja S, Rastogi A, et al. High MELD score does not adversely affect outcome of living donor liver transplantation: experience in 1000 recipients. Clin Transplant 2017; 31: e13009.